To understand the mechanism of the analgesic action of CCL-2d or LCC-09, we used DRG from RA mice with or without CCL-2d or LCC-09 treatment and examined TDAG8 gene expression. The gene discussed is GPR65; the disease is rheumatoid arthritis.